Endocrine Function and Metabolic Outcomes in Pancreas and Islet Transplantation

  • R. Paul Robertson


This chapter will deal primarily with function of the pancreatic islet and the metabolic consequences of restored hormone secretion in successful type 1 diabetic recipients of pancreas and pancreatic islets. Other considerations include endocrine function after autoislet transplant in nondiabetic subjects as well as the metabolic outcomes in donors who have undergone hemipancreatectomy for the purposes of organ donation to siblings. In selecting citations for the references used in the chapter, primary emphasis has been placed on full-length articles describing research in humans and published in peerreviewed journals.


Islet Transplantation Hepatic Glucose Production Pancreas Transplantation Acute Insulin Response Insulin Independence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Robertson RP. Pancreas and islet transplants for patients with diabetes: Taking positions and making decisions. Endocrine Practice 1999; 5: 24–28.Google Scholar
  2. 2.
    Babazono T, et al. Circulating proinsulin levels in insulin-dependent diabetic patients after whole pancreas-kidney transplantation. Metabolism 1998; 47: 1325–1330.PubMedCrossRefGoogle Scholar
  3. 3.
    Barrou Z, Seaquist ER, and Robertson RP. Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia. Diabetes 1994; 43: 661–666.PubMedCrossRefGoogle Scholar
  4. 4.
    Battezzati A, et al. Persistence of counter-regulatory abnormalities in insulin-dependent diabetes mellitus after pancreas transplantation. Eur J Clin Invest 1994; 24: 751–758.PubMedCrossRefGoogle Scholar
  5. 5.
    Battezzati A., et al. Spontaneous hypoglycaemia after pancreas transplantation in type 1 diabetes mellitus. Diabetes Med 1998; 15: 991–996.CrossRefGoogle Scholar
  6. 6.
    Barrou B, Barrou Z, Gruessner A, et al. Probability of retaining endocrine function (insulin independence) after definitive loss of exocrine function in bladder-drained pancreas transplants. Transplant Proc. 1994; 26: 473–474.PubMedGoogle Scholar
  7. 7.
    Blackman JD, et al. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes 1992; 41: 1346–1354.PubMedCrossRefGoogle Scholar
  8. 8.
    Boden G, et al. Insulin receptor down-regulation and impaired antilipolytic action of insulin in diabetic patients after pancreas/kidney transplantation. J Clin Endocrinol Metab 1994; 78: 657–663.PubMedCrossRefGoogle Scholar
  9. 9.
    Boden G, et al. Glucose metabolism and leg blood flow after pancreas/kidney transplantation. J Clin Endocrinol Metab 1993; 76: 1229–1233.PubMedCrossRefGoogle Scholar
  10. 10.
    Bolinder J, et al. Effect of pancreas transplantation on glucose counterregulation in insulin-dependent diabetic patients prone to severe hypoglycaemia. J Intern Med 1991; 230: 527–533.PubMedCrossRefGoogle Scholar
  11. 11.
    Bosi E, et al. Response of glucagon and insulin secretion to insulin-induced hypoglycaemia in type 1 diabetic patients after pancreatic transplantation. Diabetes Nutr Metab 1988; 1: 21–27.Google Scholar
  12. 12.
    Brekke IB, Oyasaeter S, and Vidnes J. Long-term effect of pancreas transplantation on diabetic hyperglucagonemia. Eur Surg Res 1982; 14: 211–220.PubMedCrossRefGoogle Scholar
  13. 13.
    Christiansen E. Metabolic consequences of successful simultaneous pancreas-kidney transplantation in humans. Diabetes Rev 1999; 7: 187–216.Google Scholar
  14. 14.
    Christiansen E, et al. Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation. Am J Physiol 1993; 264 (3, pt 1): E441 - E449.PubMedGoogle Scholar
  15. 15.
    Christiansen E, et al. Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation. J Clin Endocrinol Metab 1996; 81: 3972–3979.PubMedCrossRefGoogle Scholar
  16. 16.
    Christiansen E, et al. Insulin secretion, insulin action and noninsulin-dependent glucose uptake in pancreas transplant recipients. J Clin Endocrinol Metab 1994; 79: 1561–1569.PubMedCrossRefGoogle Scholar
  17. 17.
    Christiansen E, et al. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab 1997; 82: 2299–2307.PubMedCrossRefGoogle Scholar
  18. 18.
    Christiansen E, et al. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes 1996; 45: 1267–1275.PubMedCrossRefGoogle Scholar
  19. 19.
    Coker RH, et al. Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics. Am J Physiol 1999; 277 (6, pt 1): E1122 - E1129.PubMedGoogle Scholar
  20. 20.
    Connolly A. Metabolic control of insulin dependent diabetes after pancreas transplantation. Br Med J Clin Res 1985; 291 (6497): 737–738.CrossRefGoogle Scholar
  21. 21.
    Cottrell DA. Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: A 48-month cross-sectional study-a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3513–3519.Google Scholar
  22. 22.
    Cottrell DA, et al. Hypoglycemia after successful pancreas transplantation in type I diabetic patients. Diabetes Care 1991; 14: 1111–1113.PubMedGoogle Scholar
  23. 23.
    Cottrell DA, et al. Sequential metabolic studies of pancreas allograft function in type 1 diabetic recipients. Diabetes Med 1992; 9: 438–443.CrossRefGoogle Scholar
  24. 24.
    Diem P, et al. Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 1990; 39: 534–540.PubMedCrossRefGoogle Scholar
  25. 25.
    Diem P, et al. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 1990; 86: 2008–2013.PubMedCrossRefGoogle Scholar
  26. 26.
    Elahi E, et al. Islet cell responses to glucose in human transplanted pancreas. Am J Physiol 1991; 261 (6, pt 1): E800 - E808.PubMedGoogle Scholar
  27. 27.
    Elahi D, et al. Sequential evaluation of islet cell responses to glucose in the transplanted pancreas in humans. Am J Surg pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients. Diabetes 1990; 39: 1235–1242.Google Scholar
  28. 28.
    Fanelli CG, et al. Meticulous prevention of hypoglycemia nor malizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993; 42: 1683–1689.PubMedCrossRefGoogle Scholar
  29. 29.
    Himal HS, et al. Exocrine and endocrine functions of the allo grafted pancreas. Can Med Assoc J 1969; 100 (9): 422–427.PubMedGoogle Scholar
  30. 30.
    Holdaas H, et al. Long-term metabolic control in recipients of combined pancreas and kidney transplants. Diabetologia 1991; 34 (suppl 1): S68 - S70.PubMedCrossRefGoogle Scholar
  31. 31.
    Katz H, et al. Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 1991; 325: 1278–1283.PubMedCrossRefGoogle Scholar
  32. 32.
    Kendall DM, et al. Pancreas transplantation restores epineph rine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 1997; 46: 249–257.PubMedCrossRefGoogle Scholar
  33. 33.
    Kern W, et al. Sustained oscillatory insulin secretion after pan creas transplantation. Horm Metab Res 1990;22(12):6’14 646.Google Scholar
  34. 34.
    Landgraf R, et al. Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas t and kidney transplantation. Diabetologia 1991; 34 (suppl 1): S61 - S67.PubMedCrossRefGoogle Scholar
  35. 35.
    Larsen JL, et al. Hypoglycemic symptoms following pancreas transplantation. Clin Transplant 1993; 7: 520–524.Google Scholar
  36. 36.
    Luzi L, et al. Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes 1992; 41: 1632–1639.PubMedCrossRefGoogle Scholar
  37. 37.
    Luzi L, et al. Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients. Diabetes 1996; 45: 354–360.PubMedCrossRefGoogle Scholar
  38. 38.
    Luzi L, et al. Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) di abetic patients. Diabetologia 1990; 33: 549–556.PubMedCrossRefGoogle Scholar
  39. 39.
    Luzi L, et al. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic pa tients. Diabetes 2001; 50: 277–282.PubMedCrossRefGoogle Scholar
  40. 40.
    Nankivell BJ, et al. Clinical determinants of glucose home ostasis after pancreas transplantation. Transplantation 1996; 61: 1705–1711.PubMedCrossRefGoogle Scholar
  41. 41.
    Nauck M, et al. Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C peptide profiles in the basal state and after oral glucose. Dia betologia 1991; 34(suppl 1): S 81-S 85.Google Scholar
  42. 42.
    Nauck MA, et al. Basal and nutrient-stimulated pancreatic and gastrointestinal hormone concentrations in type-1-diabetic pa tients after successful combined pancreas and kidney transplantation. Clin Invest 1992; 70: 40–48.CrossRefGoogle Scholar
  43. 43.
    Nauck MA, et al. Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation. Acta Diabetol 1993; 30: 39–45.PubMedCrossRefGoogle Scholar
  44. 44.
    O’Meara NM, et al. Oscillatory insulin secretion after pancreas transplant. Diabetes 1993; 42: 855–861.PubMedCrossRefGoogle Scholar
  45. 45.
    Osei K. Post-transplantation hypoglycaemia in type 1 diabetic pancreas allograft recipients. Acta Diabetol 1998; 35: 176–182.PubMedCrossRefGoogle Scholar
  46. 46.
    Osei K, et al. Minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in type 1 (insulin-dependent) diabetic pancreas allograft recipients. Diabetologia 1992; 35: 676–680.PubMedCrossRefGoogle Scholar
  47. 47.
    Osei K, et al. Physiological and pharmacological stimulation of 1993; 165: 15–22.Google Scholar
  48. 48.
    Ostman J, et al. Plasma C-peptide and serum insulin antibod ies in diabetic patients receiving pancreatic transplants. Dia ies in diabetic patients receiving pancreatic transplants. Dia betologia 1980; 19: 25–30.Google Scholar
  49. 49.
    Pfeffer F, et al. Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantaglucose tolerance after combined pancreas-kidney transplantation in IDDM patients. Diabetologia 1996; 39: 462–468.PubMedCrossRefGoogle Scholar
  50. 50.
    Pozza G, et al. Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation. Br Med J Clin Res 1985; 291 (6494): 510–513.CrossRefGoogle Scholar
  51. 51.
    Pozza G, et al. Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplanent) diabetic patients following successful pancreas transplantation. Diabetologia 1983; 24: 244–248.PubMedCrossRefGoogle Scholar
  52. 52.
    Redmon JB, Au T, and Robertson RP. Hypoglycemia after pan-creas transplantation. Diabetes Care 1998; 21: 1944–1950.PubMedCrossRefGoogle Scholar
  53. 53.
    Redmon JB, Kubo SH, and Robertson RP. Glucose, insulin, and glucagon levels during exercise in pancreas transplant recipients. Diabetes Care 1995; 18: 457–462.PubMedCrossRefGoogle Scholar
  54. 54.
    Robertson RP. Seminars in medicine of the Beth Israel Hospital, Boston: Pancreatic and islet transplantation for diabetescures or curiosities? N Engl J Med 1992; 327: 1861–1868.Google Scholar
  55. 55.
    Robertson RP, Sutherland DE, and Lanz KJ. Normoglycemia and preserved insulin secretory reserve in diabetic patients 10–18 years after pancreas transplantation. Diabetes 1999; 48: 1737–1740.PubMedCrossRefGoogle Scholar
  56. 56.
    Rooney DP, and Robertson RP. Hepatic insulin resistance after pancreas transplantation in type I diabetes. Diabetes 1996; 45: 134–138.PubMedCrossRefGoogle Scholar
  57. 57.
    Saudek F, et al. The effect of insulin resistance on glucose tolerance after pancreas and kidney transplantation. Diabetes Nutr Metab 1993; 6: 1–7.Google Scholar
  58. 58.
    Secchi A, et al. Cephalic-phase insulin and glucagon release in normal subjects and in patients receiving pancreas transplantation. Metabolism 1995; 44: 1153–1158.PubMedCrossRefGoogle Scholar
  59. 59.
    Secchi A, et al. Endocrinometabolic effects of whole versus segmental pancreas allotransplantation in diabetic patients-a two-year follow-up. Transplantation 1991; 51: 625–629.PubMedCrossRefGoogle Scholar
  60. 60.
    Secchi A, et al. Insulin secretory patterns and blood glucose homeostasis after islet allotransplantation in IDDM patients: Comparison with segmental-or whole-pancreas transplanted patients through a long term longitudinal study. J Mol Med1999; 77: 133–139.Google Scholar
  61. 61.
    Sells RA, et al. Glucose and insulin metabolism after pancreatic transplantation. Br Med J 1972; 3 (828): 678–681.PubMedCrossRefGoogle Scholar
  62. 62.
    Stratta RJ, et al. Combined pancreas-kidney transplantation: Preliminary results and metabolic effects. Am J Gastroenterol1991; 86: 697–703.Google Scholar
  63. 63.
    Teuscher AU, Seaquist ER, Robertson RP. Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients. Diabetes 1994; 43: 593–598.PubMedCrossRefGoogle Scholar
  64. 64.
    Wasada T, et al. Insulin sensitivity and negative insulin feedback after pancreas transplantation in insulin-dependent diabetic patients. Endocrinol J 1995; 42: 747–752.Google Scholar
  65. 65.
    Fellstrom B. Impact and management of hyperlipidemia posttransplantation. Transplantation 2000;70(suppl 11):SS51–SS57.Google Scholar
  66. 66.
    al’Halawani MH, et al. Pravastatin reduces serum cholesterol and low density lipoprotein concentrations following pancreas transplantation. Transplantation 1994; 58: 1204–1209.PubMedGoogle Scholar
  67. 67.
    Bagdade JD, et al. Differing effects of pancreas-kidney transplantation with systemic versus portal venous drainage on cholesteryl ester transfer in IDDM subjects. Diabetes Care 1996; 19: 1108–1112.PubMedCrossRefGoogle Scholar
  68. 68.
    Bagdade JD, et al. Alterations in cholesteryl ester transfer, lipoprotein lipase, and lipoprotein composition after combined pancreas-kidney transplantation. Diabetes 1998; 47: 113–118.PubMedCrossRefGoogle Scholar
  69. 69.
    Foger B, et al. Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol. Transplantation 1994; 58: 899–904.PubMedCrossRefGoogle Scholar
  70. 70.
    Foger B, et al. Effects of pancreas transplantation on distribution and composition of plasma lipoproteins. Metabolism 1996; 45: 856–861.PubMedCrossRefGoogle Scholar
  71. 71.
    Hughes TA, et al. Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition. Transplantation 1995; 60: 1406 1412.Google Scholar
  72. 72.
    Hughes TA, et al. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: Effect of kidney and pancreas transplantation. Metabolism 1994; 43: 333347.Google Scholar
  73. 73.
    Katz HH, et al. Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipients. Mayo Clin Proc 1994; 69: 231–236.PubMedCrossRefGoogle Scholar
  74. 74.
    La Rocca E, et al., Lipoprotein profile after combined kidney-pancreas transplantation in insulin dependent diabetes mellitus. Transplant Int 1995; 8: 190–195.Google Scholar
  75. 75.
    Larsen JL, et al. Lipid status after combined pancreas-kidney transplantation and kidney transplantation alone in type I diabetes mellitus. Transplantation 1992; 54: 992–996.PubMedCrossRefGoogle Scholar
  76. 76.
    Larsen JL, et al. Lipid status after pancreas-kidney transplantation. Diabetes Care 1992; 15: 35–42.PubMedCrossRefGoogle Scholar
  77. 77.
    Fiorina P, et al. Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 2001; 50: 496–501.PubMedCrossRefGoogle Scholar
  78. 78.
    Luzi L, et al. Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabeticuremic patients. J Clin Invest 1994; 93: 1948–1958.PubMedCrossRefGoogle Scholar
  79. 79.
    Kendall DM, et al. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans N Engl J Med 1990; 322: 898–903.Google Scholar
  80. 80.
    Seaquist ER, Robertson RP. Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 1992; 89: 1761–1766.PubMedCrossRefGoogle Scholar
  81. 81.
    Seaquist ER, et al. Insulin-mediated and glucose-mediated glucose uptake following hemipancreatectomy in healthy human donors. Diabetologia 1994; 37: 1036–1043.PubMedCrossRefGoogle Scholar
  82. 82.
    Seaquist ER, et al. Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans. J Clin Invest 1996; 97: 455–460.PubMedCrossRefGoogle Scholar
  83. 83.
    Robertson RP, Lanz KJ, Sutherland DER, Seaquist ER. Relationship between diabetes and obesity 9–18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002; 73: 736–741.PubMedCrossRefGoogle Scholar
  84. 84.
    Shapiro AM, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230–238.PubMedCrossRefGoogle Scholar
  85. 85.
    Wahoff DC, et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 1995;222:562575. Discussion 575–579.Google Scholar
  86. 86.
    Alejandro R, et al. Natural history of intrahepatic canine islet cell autografts. J Clin Invest 1986; 78: 1339–1348.PubMedCrossRefGoogle Scholar
  87. 87.
    Barone GW, et al. Glucose metabolism after pancreas auto-transplantation. The effect of open duct versus urinary bladder drainage technique. Ann Surg 1991; 213: 159–165.PubMedCrossRefGoogle Scholar
  88. 88.
    Calhoun P, et al. Evaluation of insulin secretion after pancreas autotransplantation by oral or intravenous glucose challenge. Ann Surg 1986; 204: 585–593.PubMedCrossRefGoogle Scholar
  89. 89.
    Gores PF, et al. Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 1993; 341 (8836): 19–21.PubMedCrossRefGoogle Scholar
  90. 90.
    Jaeger C, et al. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibodynegative IDDM recipients of intrahepatic islet allografts. Diabetes 1997; 46: 1907–1910.PubMedCrossRefGoogle Scholar
  91. 91.
    Kendall DM, Teuscher AU, Robertson RP. Defective glucagon secretion during sustained hypoglycemia following successful islet allo-and autotransplantation in humans. Diabetes 1997; 46: 23–27.PubMedCrossRefGoogle Scholar
  92. 92.
    Largiader F, Kolb E, Binswanger U. A long-term functioning human pancreatic islet allotransplant. Transplantation 1980; 29: 76–77.PubMedCrossRefGoogle Scholar
  93. 93.
    Luzi L, et al. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 2611–2618.PubMedCrossRefGoogle Scholar
  94. 94.
    Meyer C, et al. Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation 1998; 66: 233–240.PubMedCrossRefGoogle Scholar
  95. 95.
    Najarian JS, et al. Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg 1980; 192: 526–542.PubMedCrossRefGoogle Scholar
  96. 96.
    Pyzdrowski KL, et al. Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med 1992; 327: 220–226.PubMedCrossRefGoogle Scholar
  97. 97.
    Ricordi C, et al. Human islet allografts in patients with type 2 diabetes undergoing liver transplantation. Transplantation 1997; 63: 473–475.PubMedCrossRefGoogle Scholar
  98. 98.
    Robertson RP. Successful islet transplantation for patients with diabetes-fact or fantasy? N Engl J Med, 2000; 343: 289–290.PubMedCrossRefGoogle Scholar
  99. 99.
    Ryan EA, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710–719.PubMedCrossRefGoogle Scholar
  100. 100.
    Scharp DW, et al. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 1991; 51: 76–85.PubMedCrossRefGoogle Scholar
  101. 101.
    Scharp DW, et al. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 1990; 39: 515–518.PubMedCrossRefGoogle Scholar
  102. 102.
    Soon-Shiong P, et al. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci USA 1993; 90: 5843–5847.PubMedCrossRefGoogle Scholar
  103. 103.
    Soon-Shiong P, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994; 343 (8903): 950–951.PubMedCrossRefGoogle Scholar
  104. 104.
    Sutherland DE, et al. Islet transplantation: An update. Diabetes Metab Rev 1996; 12: 137–150.PubMedGoogle Scholar
  105. 105.
    Teuscher AU, et al. Successful islet autotransplantation in humans: Functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998; 47: 324–330.PubMedCrossRefGoogle Scholar
  106. 106.
    Robertson RP, Lanz KJ, Sutherland DER, Kendall DM. Prevention of diabetes for up to thirteen years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes 2001; 50: 47–50.PubMedCrossRefGoogle Scholar
  107. 107.
    Tzakis AG, et al. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 1990; 336 (8712): 402–405.PubMedCrossRefGoogle Scholar
  108. 108.
    Warnock GL, et al. Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 55–58.PubMedCrossRefGoogle Scholar
  109. 109.
    Warnock GL, et al. Continued function of pancreatic islets after transplantation in type I diabetes. Lancet 1989; 2 (8662): 570–572.PubMedCrossRefGoogle Scholar
  110. 110.
    Warnock GL, et al. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 89–95.PubMedCrossRefGoogle Scholar
  111. 111.
    Williams PW, Lond MD, et al. Notes on diabetes treated wtih extract and by grafts of sheep’s pancreas. Br Med J 1894(Dec 8 ): 1303–1304.Google Scholar
  112. 112.
    Gupta V, Wahoff DC, Rooney DP, Poitout V, Sutherland DE, Kendall DM, Robertson RP. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes 1997; 46: 28–33.PubMedCrossRefGoogle Scholar
  113. 113.
    Baumgartner D, Schlumpf R, Largiader F. Cyclosporine A interferes with postoperative blood glucose control after clinical pancreas transplantation. Transplant Proc 1987; 19 (5): 4009–4010.PubMedGoogle Scholar
  114. 114.
    Carroll PB, et al. Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. Transplantation 1991; 51: 276–278.Google Scholar
  115. 115.
    Delaunay F, et al. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest 1997; 100: 2094–2098.PubMedCrossRefGoogle Scholar
  116. 116.
    Drachenberg CB, et al. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999; 68 (3): 396–402.PubMedCrossRefGoogle Scholar
  117. 117.
    Ericzon BG, et al. FK506-induced impairment of glucose metabolism in the primate-studies in pancreatic transplant recipients and in nontransplanted animals. Transplantation 1992; 54: 615–620.PubMedCrossRefGoogle Scholar
  118. 118.
    Fernandez LA, et al., The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 1999; 68: 1532–1541.PubMedCrossRefGoogle Scholar
  119. 119.
    Gaber AO, et al. Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg 1995;221:613–622. Discussion 622–624.Google Scholar
  120. 120.
    Gunnarsson R, et al. Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet 1983; 2 (8349): 571–572.PubMedCrossRefGoogle Scholar
  121. 121.
    Hahn HJ, et al. Alteration of pancreatic B-cells in Wistar rats treated with non-diabetogenic doses of cyclosporin A. Pharmacol Toxicol 1992; 70 (3): 188–191.PubMedCrossRefGoogle Scholar
  122. 122.
    Herold KC, et al. Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. Transplantation 1993; 55: 186–192.PubMedCrossRefGoogle Scholar
  123. 123.
    Kneteman NM, et al. Effects of cyclosporine on insulin secretion and insulin sensitivity in dogs with intrasplenic islet auto-transplants. Surgery 1992; 111: 430–437.PubMedGoogle Scholar
  124. 124.
    Neto AB, et al. Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets. Transplant hit 1999; 12: 208–212.Google Scholar
  125. 125.
    Odocha O, et al. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc 1993; 25 (4): 2433–2434.PubMedGoogle Scholar
  126. 126.
    Redmon JB, et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996; 98: 2786–2793.PubMedCrossRefGoogle Scholar
  127. 127.
    Robertson RP. Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 1986; 35: 1016–1019.PubMedCrossRefGoogle Scholar
  128. 128.
    Roth D, et al. Posttransplant hyperglycemia. Increased incidence in cyclosporin-treated renal allograft recipients. Transplantation 1989; 47: 278–281.PubMedCrossRefGoogle Scholar
  129. 129.
    Yamamoto H, et al. Effects of cyclosporin A and low dosages of steroid on posttransplantation diabetes in kidney transplant recipients. Diabetes Care 1991; 14: 867–870.PubMedCrossRefGoogle Scholar
  130. 130.
    Yoshimura N, et al. Effect of cyclosporin on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988; 12: 11–17.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • R. Paul Robertson

There are no affiliations available

Personalised recommendations